Imunon, Inc. — Director's Dealing 2015

Dec 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2015-12-15

Reporting Person: Voss Andreas (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-15	Option to Purchase Celsion Corporation Common Stock	$1.78	A	30000	Acquired	2025-12-15	Celsion Corporation Common Stock (30000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on December 15, 2016, December 15, 2017 and December 15, 2018.